Close

Cellectar Biosciences (CLRB) Announces Positive Data from Second Cohort of CLR 131 Phase 1 in r/r Multiple Myeloma

Go back to Cellectar Biosciences (CLRB) Announces Positive Data from Second Cohort of CLR 131 Phase 1 in r/r Multiple Myeloma
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Delayed: 3.21 -0.1 (3.02%)
Previous Close $3.31    52 Week High $6.03 
Open $3.32    52 Week Low $0.41 
Day High $3.37    P/E N/A 
Day Low $3.17    EPS $0.00 
Volume 848,742       

(NASDAQ: CLRBW) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High $1.40 
Open $0.88    52 Week Low $0.11 
Day High $0.13    P/E N/A 
Day Low $0.13    EPS $0.00 
Volume 214,095       

(NASDAQ: CLRBZ) Delayed: 0.12 --0 (-0%)
Previous Close $0.12    52 Week High $1.88 
Open $58.27    52 Week Low $0.25 
Day High $0.12    P/E N/A 
Day Low $0.12    EPS $0.00 
Volume 6,852